00301-5/assets/gr3.jpg)
Expression of androgen receptor (AR) in benign prostatic hyperplasia (BPH; left panel) and recurrent prostate cancer (right panel), with AR immunostaining shown in brown. Reproduced with permission from John Wiley & Sons Inc. [8].
Expression of androgen receptor (AR) in benign prostatic hyperplasia (BPH; left panel) and recurrent prostate cancer (right panel), with AR immunostaining shown in brown. Reproduced with permission from John Wiley & Sons Inc. [8].
Copyright © Elsevier B.V. All rights reserved
